Supplements With Proton Pump Inhibitors: A Modest Proposal

The Oasis Health Journal · Submitted October 14, 2026 · 3:00 PM EDT

By June Mackerel · Edited by Colette Ward

Proton pump inhibitors do precisely what the name suggests. They inhibit the proton pump in the stomach lining, thereby reducing the secretion of gastric acid. For ulcers and related unpleasantness, this is considered a therapeutic triumph. For the absorption of minerals and certain vitamins, it is rather less helpful.

The stomach produces acid for reasons beyond the inconvenience of heartburn. That acid also unbinds minerals from food, activates certain enzymes and assists with the absorption of nutrients that require an acidic environment. When one suppresses the acid for months or years at a time, those other functions do not politely wait for the prescription to end.

The question, then, is whether there is anything to be done about it, and whether supplements with proton pump inhibitors represent a sensible mitigation or merely another item on the daily pill roster.

What the Research Shows About Nutrient Deficiency on PPI Medications

In a cross-sectional analysis of twenty-three thousand three hundred and sixty-three American adults, published in the journal Pharmacoepidemiology and Drug Safety in twenty twenty-six, researchers examined the association between proton pump inhibitor use and malnutrition risk according to the Global Leadership Initiative on Malnutrition criteria. The GLIM framework integrates phenotypic and etiologic markers of nutritional status.

The prevalence of malnutrition in the study population was eighteen point nine percent. Proton pump inhibitor use was associated with a ten percent increased risk of malnutrition after adjustment for sociodemographics, food security, comorbidities and appetite-affecting medications.

One is invited to consider what, precisely, is being treated here, and at what cost.

For severe malnutrition, the association was notably stronger. Proton pump inhibitor exposure was associated with an odds ratio of one point three six. In the population aged sixty-five and older, chronic proton pump inhibitor use increased the odds of severe malnutrition by fifty-seven percent.

The authors noted that prolonged iatrogenic hypochlorhydria may represent an important contributor to malnutrition, particularly among older adults. They suggested that regular medication reviews might be in order to identify and discontinue unnecessary long-term therapy. One imagines the implication was not lost on the prescribing physicians, though whether anyone acted on it is a separate matter.

How to Restore Mineral Absorption on Proton Pump Inhibitors

A review published in Reviews in Endocrine and Metabolic Disorders in twenty twenty-two examined factors influencing the absorption of levothyroxine, a thyroid hormone replacement that also depends on gastric acidity for proper uptake. The authors developed a rather comprehensive decision tree for physicians faced with patients whose thyroid-stimulating hormone levels remained abnormally high despite reported compliance with the recommended dose.

The list of interfering factors was extensive. Mineral supplements, dietary fibre, resins, various drugs, Helicobacter pylori infection, ulcerative colitis, coeliac disease, bariatric surgery, food intolerance, gastritis and anything else that alters the state of the epithelium in the stomach or small intestine were all noted to reduce or slow absorption. Proton pump inhibitors appeared on that list as well, which one supposes is the reason we are here.

The difficulty with mineral absorption is that the minerals must first be ionised, which requires acid. Calcium, magnesium, iron and zinc are all affected. Magnesium supplements, for instance, are absorbed more efficiently in acidic conditions. When the stomach is producing rather less acid than usual, the mineral simply passes through, unabsorbed, and one is left with an expensive urine sample and no particular benefit.

The same review noted that vitamin B twelve absorption is similarly compromised. B twelve must be cleaved from dietary protein by pepsin, an enzyme that requires an acidic environment to function. Proton pump inhibitors reduce both the acid and the pepsin activity, which presents something of a logistical problem for anyone hoping to absorb the vitamin from food.

One solution, though 'solution' may be rather a strong word, is to take vitamin B twelve supplements in a form that does not require gastric acid for absorption. Sublingual or intramuscular preparations bypass the stomach entirely, which is efficient if one does not mind the needle or the odd taste under the tongue.

Iodine Supplement Timing With PPI Drugs

Iodine absorption is also affected by gastric pH, though the evidence here is somewhat thinner. A review published in Pharmaceuticals in twenty twenty-five noted that proton pump inhibitors can affect the balance of the gut microbiota, causing dysbiosis, which in turn may lead to other metabolic disturbances. The connection between dysbiosis and iodine absorption is not entirely clear, but one imagines the researchers are working on it.

The practical question for anyone taking both a proton pump inhibitor and an iodine supplement is when, precisely, to take each. The standard recommendation is to separate the doses by at least two hours, ideally more, so that the stomach has some opportunity to recover a degree of acidity before the mineral arrives.

It is rather like trying to coordinate a dinner party where half the guests cannot tolerate the other half. One must stagger the arrivals and hope nobody notices the awkwardness.

The timing strategy applies to calcium and iron as well. Taking them at the same time as the proton pump inhibitor defeats the purpose of taking them at all. One might as well save the money and skip the supplement entirely, though this is not generally what the pharmacist recommends.

Best Supplements With Proton Pump Inhibitors: A Practical Summary

For individuals on long-term proton pump inhibitor therapy, the evidence suggests monitoring and, where appropriate, supplementing several nutrients. Vitamin B twelve, magnesium, calcium, iron and possibly iodine are all candidates for supplementation, depending on baseline levels and duration of therapy.

The timing of supplementation matters. Taking minerals at the same time as the proton pump inhibitor accomplishes very little. Spacing them by at least two to four hours allows the stomach to recover some degree of acidity, which improves absorption. This requires a degree of organisational commitment that one may or may not possess at six in the morning, but it is the system we have.

The best magnesium supplement for PPI users is generally one that does not rely solely on gastric acid for absorption. Magnesium citrate, glycinate or malate are often recommended over magnesium oxide, which is poorly absorbed even under ideal conditions. One imagines the oxide form is cheaper, which may explain its continued popularity.

What supplements to take with proton pump inhibitors is ultimately a question for one's clinician, who presumably has access to one's laboratory results and medical history. The research suggests that monitoring is warranted, particularly for older adults, individuals on long-term therapy and anyone exhibiting signs of deficiency such as fatigue, muscle weakness or unexplained changes in health status.

The alternative, of course, is to discontinue the proton pump inhibitor if it is no longer medically necessary. The twenty twenty-six analysis rather pointedly suggested that regular medication reviews might identify individuals for whom long-term therapy is not indicated. One does wonder how many prescriptions are renewed out of habit rather than necessity.

In the meantime, those who remain on therapy may wish to have a conversation with their clinician about which nutrients to monitor, which to supplement and what time of day to take each pill so that none of them interfere with the others.

It is a modest inconvenience, rather than a catastrophe, but it is an inconvenience nonetheless.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Drugs Versus Microbiota: How Pharmacotherapy Affects Gut and Probiotic Bacteria, Pharmaceuticals (Basel, Switzerland) (2025).
2. Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults, Reviews in endocrine & metabolic disorders (2022).
3. Nutrigenomics-Associated Impacts of Nutrients on Genes and Enzymes With Special Consideration of Aromatase, Frontiers in nutrition (2020).
4. Association Between Proton Pump Inhibitor Use and Malnutrition Risk in the US General Population Using the GLIM Framework (NHANES 1999-2020), Pharmacoepidemiology and drug safety (2026).